The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $0.72 in the prior trading day, Aethlon Medical Inc (NASDAQ: AEMD) closed at $0.67, down -6.65%. In other words, the price has decreased by -$6.65 from its previous closing price. On the day, 1.43 million shares were traded. AEMD stock price reached its highest trading level at $0.722 during the session, while it also had its lowest trading level at $0.61.
Ratios:
Our goal is to gain a better understanding of AEMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.48 and its Current Ratio is at 2.48. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.08.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEMD now has a Market Capitalization of 1751530 and an Enterprise Value of -1327043.
Stock Price History:
The Beta on a monthly basis for AEMD is 1.99, which has changed by -0.7736486 over the last 52 weeks, in comparison to a change of 0.18189907 over the same period for the S&P500. Over the past 52 weeks, AEMD has reached a high of $8.44, while it has fallen to a 52-week low of $0.69. The 50-Day Moving Average of the stock is -47.52%, while the 200-Day Moving Average is calculated to be -78.12%.
Shares Statistics:
The stock has traded on average 2.98M shares per day over the past 3-months and 1652610 shares per day over the last 10 days, according to various share statistics. A total of 2.60M shares are outstanding, with a floating share count of 2.49M. Insiders hold about 4.05% of the company’s shares, while institutions hold 15.43% stake in the company. Shares short for AEMD as of 1755216000 were 121116 with a Short Ratio of 0.04, compared to 1752537600 on 229563. Therefore, it implies a Short% of Shares Outstanding of 121116 and a Short% of Float of 4.7.
Earnings Estimates
A comprehensive evaluation of Aethlon Medical Inc (AEMD) is underway, with the input of 2.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.25 and low estimates of -$0.72.
Analysts are recommending an EPS of between -$1.45 and -$3.05 for the fiscal current year, implying an average EPS of -$2.25. EPS for the following year is -$0.57, with 1.0 analysts recommending between -$0.57 and -$0.57.